Sorry, you need to enable JavaScript to visit this website.

Information for healthcare professionals on obesity including guidelines, protocols and evidence on the use of VLCDs.

Obesity Week 2021 Proceedings: The Clinical and Therapeutic Implications of Meal Replacements: Sustained Weight Loss for Improved Liver Health and Diabetes Remission

Nestle Health Science

Type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD) are highly prevalent diseases associated with an increased risk of morbidity and mortality. Obesity/overweight and dietary intake are important risk factors. Jamy Ard focused on the benefits of meal replacements to promote increased weight loss and increased rates of T2DM remission. Wajahat Mehal discussed sustained weight loss and improved liver health and focused on meal replacements and very-low-calorie diets (VLCD)for the management of NAFLD/NASH.